Ocular Therapeutix, Inc. (OCUL)
7.13
-0.18
(-2.46%)
USD |
NASDAQ |
Oct 30, 12:34
Ocular Therapeutix Total Return Level : 7.31 for Oct. 29, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 29, 2026 | 7.31 |
| October 28, 2026 | 7.29 |
| October 27, 2026 | 6.72 |
| October 26, 2026 | 6.47 |
| October 23, 2026 | 6.50 |
| October 22, 2026 | 6.61 |
| October 21, 2026 | 6.48 |
| October 20, 2026 | 6.65 |
| October 19, 2026 | 6.29 |
| October 16, 2026 | 6.87 |
| October 15, 2026 | 7.38 |
| October 14, 2026 | 7.20 |
| October 13, 2026 | 7.24 |
| October 12, 2026 | 7.56 |
| October 09, 2026 | 7.54 |
| October 08, 2026 | 7.51 |
| October 07, 2026 | 7.23 |
| October 06, 2026 | 7.34 |
| October 05, 2026 | 7.25 |
| October 02, 2026 | 6.96 |
| October 01, 2026 | 7.29 |
| September 30, 2026 | 7.67 |
| September 29, 2026 | 7.87 |
| September 28, 2026 | 7.655 |
| September 25, 2026 | 9.65 |
| Date | Value |
|---|---|
| September 24, 2026 | 9.82 |
| September 23, 2026 | 10.00 |
| September 22, 2026 | 10.50 |
| September 21, 2026 | 9.99 |
| September 18, 2026 | 9.99 |
| September 17, 2026 | 10.14 |
| September 16, 2026 | 9.87 |
| September 15, 2026 | 10.19 |
| September 14, 2026 | 10.72 |
| September 11, 2026 | 10.49 |
| September 10, 2026 | 10.62 |
| September 09, 2026 | 11.47 |
| September 08, 2026 | 11.37 |
| September 04, 2026 | 10.64 |
| September 03, 2026 | 10.64 |
| September 02, 2026 | 10.90 |
| September 01, 2026 | 10.57 |
| August 31, 2026 | 10.49 |
| August 28, 2026 | 10.36 |
| August 27, 2026 | 10.82 |
| August 26, 2026 | 10.77 |
| August 25, 2026 | 10.88 |
| August 24, 2026 | 10.78 |
| August 21, 2026 | 11.08 |
| August 20, 2026 | 11.09 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| EyePoint, Inc. | 0.38 |
| ANI Pharmaceuticals, Inc. | 73.16 |
| Eli Lilly & Co. | 3629.60 |
| Corcept Therapeutics, Inc. | 85.95 |
| Veru, Inc. | 2.607 |